Annual EBITDA
-$31.68 M
-$12.01 M-61.07%
31 December 2023
Summary:
AIM ImmunoTech annual earnings before interest, taxes, depreciation & amortization is currently -$31.68 million, with the most recent change of -$12.01 million (-61.07%) on 31 December 2023. During the last 3 years, it has fallen by -$18.68 million (-143.77%). AIM annual EBITDA is now -1633.30% below its all-time high of $2.07 million, reached on 31 December 2003.AIM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.44 M
-$1.84 M-115.23%
30 September 2024
Summary:
AIM ImmunoTech quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.44 million, with the most recent change of -$1.84 million (-115.23%) on 30 September 2024. Over the past year, it has increased by +$4.33 million (+55.75%). AIM quarterly EBITDA is now -267.97% below its all-time high of $2.04 million, reached on 30 September 2003.AIM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$26.19 M
+$4.33 M+14.18%
30 September 2024
Summary:
AIM ImmunoTech TTM earnings before interest, taxes, depreciation & amortization is currently -$26.19 million, with the most recent change of +$4.33 million (+14.18%) on 30 September 2024. Over the past year, it has dropped by -$4.60 million (-21.29%). AIM TTM EBITDA is now -819.31% below its all-time high of $3.64 million, reached on 30 June 2004.AIM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.1% | +55.8% | -21.3% |
| 3 y3 years | -143.8% | +5.4% | -60.7% |
| 5 y5 years | -275.0% | -34.2% | -211.9% |
AIM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -143.8% | at low | -115.2% | +77.8% | -60.7% | +22.4% |
| 5 y | 5 years | -287.0% | at low | -246.6% | +77.8% | -219.7% | +22.4% |
| alltime | all time | -1633.3% | at low | -268.0% | +77.8% | -819.3% | +22.4% |
AIM ImmunoTech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.44 M(+115.2%) | -$26.19 M(-14.2%) |
| June 2024 | - | -$1.60 M(-71.9%) | -$30.52 M(-9.6%) |
| Mar 2024 | - | -$5.69 M(-63.2%) | -$33.75 M(+6.5%) |
| Dec 2023 | -$31.68 M(+61.1%) | -$15.47 M(+99.3%) | -$31.68 M(+46.7%) |
| Sept 2023 | - | -$7.76 M(+60.8%) | -$21.59 M(+6.2%) |
| June 2023 | - | -$4.83 M(+33.6%) | -$20.32 M(+0.0%) |
| Mar 2023 | - | -$3.61 M(-32.9%) | -$20.32 M(+2.5%) |
| Dec 2022 | -$19.67 M(+7.6%) | -$5.39 M(-17.0%) | -$19.82 M(-1.3%) |
| Sept 2022 | - | -$6.49 M(+34.7%) | -$20.09 M(+16.6%) |
| June 2022 | - | -$4.82 M(+54.4%) | -$17.23 M(-4.7%) |
| Mar 2022 | - | -$3.12 M(-44.7%) | -$18.08 M(-1.0%) |
| Dec 2021 | -$18.29 M(+40.7%) | -$5.65 M(+55.7%) | -$18.26 M(+12.1%) |
| Sept 2021 | - | -$3.63 M(-36.1%) | -$16.30 M(+3.2%) |
| June 2021 | - | -$5.68 M(+72.0%) | -$15.79 M(+21.3%) |
| Mar 2021 | - | -$3.30 M(-10.4%) | -$13.02 M(+0.1%) |
| Dec 2020 | -$12.99 M(+58.8%) | -$3.69 M(+18.1%) | -$13.01 M(+26.1%) |
| Sept 2020 | - | -$3.12 M(+7.4%) | -$10.31 M(+5.8%) |
| June 2020 | - | -$2.90 M(-11.8%) | -$9.75 M(+13.7%) |
| Mar 2020 | - | -$3.29 M(+232.5%) | -$8.58 M(+4.7%) |
| Dec 2019 | -$8.19 M(-3.1%) | -$991.00 K(-61.3%) | -$8.19 M(-2.5%) |
| Sept 2019 | - | -$2.56 M(+47.7%) | -$8.40 M(-2.5%) |
| June 2019 | - | -$1.73 M(-40.4%) | -$8.62 M(-4.1%) |
| Mar 2019 | - | -$2.91 M(+142.9%) | -$8.99 M(+6.5%) |
| Dec 2018 | -$8.45 M(+18.8%) | -$1.20 M(-56.9%) | -$8.44 M(-5.6%) |
| Sept 2018 | - | -$2.78 M(+32.2%) | -$8.94 M(+26.0%) |
| June 2018 | - | -$2.10 M(-10.9%) | -$7.09 M(+2.5%) |
| Mar 2018 | - | -$2.36 M(+38.7%) | -$6.92 M(-2.7%) |
| Dec 2017 | -$7.11 M(+14.7%) | -$1.70 M(+81.8%) | -$7.11 M(+13.6%) |
| Sept 2017 | - | -$935.00 K(-51.5%) | -$6.26 M(-20.3%) |
| June 2017 | - | -$1.93 M(-24.3%) | -$7.85 M(+13.6%) |
| Mar 2017 | - | -$2.55 M(+200.0%) | -$6.91 M(-10.4%) |
| Dec 2016 | -$6.20 M(-55.8%) | -$849.00 K(-66.4%) | -$7.71 M(-20.0%) |
| Sept 2016 | - | -$2.53 M(+156.2%) | -$9.64 M(-9.2%) |
| June 2016 | - | -$987.00 K(-70.5%) | -$10.62 M(-25.2%) |
| Mar 2016 | - | -$3.35 M(+20.6%) | -$14.19 M(+1.1%) |
| Dec 2015 | -$14.04 M(-13.9%) | -$2.78 M(-20.9%) | -$14.04 M(-9.4%) |
| Sept 2015 | - | -$3.51 M(-23.0%) | -$15.49 M(-2.4%) |
| June 2015 | - | -$4.56 M(+42.8%) | -$15.87 M(-0.7%) |
| Mar 2015 | - | -$3.19 M(-24.5%) | -$15.99 M(-1.9%) |
| Dec 2014 | -$16.30 M(+6.2%) | -$4.23 M(+8.6%) | -$16.30 M(+8.3%) |
| Sept 2014 | - | -$3.89 M(-16.8%) | -$15.04 M(-6.4%) |
| June 2014 | - | -$4.68 M(+33.6%) | -$16.07 M(+4.2%) |
| Mar 2014 | - | -$3.50 M(+17.7%) | -$15.42 M(+0.5%) |
| Dec 2013 | -$15.34 M(-7.8%) | -$2.97 M(-39.6%) | -$15.34 M(-13.0%) |
| Sept 2013 | - | -$4.92 M(+22.3%) | -$17.64 M(-7.7%) |
| June 2013 | - | -$4.02 M(+17.6%) | -$19.10 M(+6.6%) |
| Mar 2013 | - | -$3.42 M(-35.0%) | -$17.92 M(+7.7%) |
| Dec 2012 | -$16.65 M(+99.5%) | -$5.27 M(-17.5%) | -$16.65 M(+16.2%) |
| Sept 2012 | - | -$6.38 M(+124.0%) | -$14.33 M(+36.5%) |
| June 2012 | - | -$2.85 M(+32.8%) | -$10.50 M(+6.6%) |
| Mar 2012 | - | -$2.15 M(-27.2%) | -$9.85 M(+18.0%) |
| Dec 2011 | -$8.34 M(-32.4%) | -$2.95 M(+15.3%) | -$8.34 M(+11.8%) |
| Sept 2011 | - | -$2.56 M(+16.3%) | -$7.46 M(-13.4%) |
| June 2011 | - | -$2.20 M(+242.4%) | -$8.62 M(+11.6%) |
| Mar 2011 | - | -$642.00 K(-69.0%) | -$7.72 M(-37.5%) |
| Dec 2010 | -$12.35 M(-1.4%) | -$2.07 M(-44.3%) | -$12.35 M(-11.9%) |
| Sept 2010 | - | -$3.71 M(+185.8%) | -$14.01 M(+11.0%) |
| June 2010 | - | -$1.30 M(-75.3%) | -$12.62 M(-16.7%) |
| Mar 2010 | - | -$5.27 M(+41.0%) | -$15.15 M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$12.52 M(+3.5%) | -$3.74 M(+61.1%) | -$12.52 M(+7.5%) |
| Sept 2009 | - | -$2.32 M(-39.4%) | -$11.65 M(-7.9%) |
| June 2009 | - | -$3.83 M(+44.7%) | -$12.65 M(+8.9%) |
| Mar 2009 | - | -$2.64 M(-7.6%) | -$11.62 M(-3.9%) |
| Dec 2008 | -$12.10 M(-34.9%) | -$2.86 M(-13.9%) | -$12.10 M(-5.8%) |
| Sept 2008 | - | -$3.32 M(+19.1%) | -$12.85 M(-17.6%) |
| June 2008 | - | -$2.79 M(-10.5%) | -$15.59 M(-7.5%) |
| Mar 2008 | - | -$3.12 M(-13.6%) | -$16.86 M(-9.2%) |
| Dec 2007 | -$18.57 M(+4.8%) | -$3.61 M(-40.5%) | -$18.57 M(-0.5%) |
| Sept 2007 | - | -$6.07 M(+49.6%) | -$18.66 M(+14.3%) |
| June 2007 | - | -$4.06 M(-16.1%) | -$16.32 M(-4.1%) |
| Mar 2007 | - | -$4.83 M(+30.8%) | -$17.02 M(-3.9%) |
| Dec 2006 | -$17.71 M(+161.0%) | -$3.70 M(-1.0%) | -$17.71 M(+23.8%) |
| Sept 2006 | - | -$3.73 M(-21.5%) | -$14.30 M(+12.8%) |
| June 2006 | - | -$4.76 M(-13.9%) | -$12.69 M(+23.2%) |
| Mar 2006 | - | -$5.53 M(+1839.6%) | -$10.29 M(+51.7%) |
| Dec 2005 | -$6.79 M(-602.0%) | -$285.00 K(-86.5%) | -$6.79 M(-6.0%) |
| Sept 2005 | - | -$2.12 M(-10.6%) | -$7.22 M(+104.7%) |
| June 2005 | - | -$2.37 M(+17.1%) | -$3.53 M(-1055.8%) |
| Mar 2005 | - | -$2.02 M(+181.5%) | $369.00 K(-72.7%) |
| Dec 2004 | $1.35 M(-34.6%) | -$718.00 K(-145.5%) | $1.35 M(-57.4%) |
| Sept 2004 | - | $1.58 M(+3.3%) | $3.17 M(-12.8%) |
| June 2004 | - | $1.53 M(-247.2%) | $3.64 M(+45.4%) |
| Mar 2004 | - | -$1.04 M(-193.9%) | $2.50 M(+21.2%) |
| Dec 2003 | $2.07 M(-132.7%) | $1.11 M(-45.9%) | $2.07 M(-1407.6%) |
| Sept 2003 | - | $2.04 M(+421.7%) | -$158.00 K(-96.1%) |
| June 2003 | - | $392.00 K(-126.5%) | -$4.04 M(-36.4%) |
| Mar 2003 | - | -$1.48 M(+32.1%) | -$6.34 M(+0.3%) |
| Dec 2002 | -$6.32 M(-23.6%) | -$1.12 M(-39.0%) | -$6.32 M(-6.1%) |
| Sept 2002 | - | -$1.83 M(-4.3%) | -$6.73 M(-3.2%) |
| June 2002 | - | -$1.92 M(+31.7%) | -$6.96 M(-4.8%) |
| Mar 2002 | - | -$1.46 M(-4.8%) | -$7.31 M(-11.7%) |
| Dec 2001 | -$8.28 M(-3.2%) | -$1.53 M(-25.7%) | -$8.28 M(-9.3%) |
| Sept 2001 | - | -$2.06 M(-9.3%) | -$9.12 M(+0.0%) |
| June 2001 | - | -$2.27 M(-6.2%) | -$9.12 M(+2.0%) |
| Mar 2001 | - | -$2.42 M(+1.9%) | -$8.94 M(+4.5%) |
| Dec 2000 | -$8.56 M(-31.3%) | -$2.37 M(+15.3%) | -$8.56 M(-23.6%) |
| Sept 2000 | - | -$2.06 M(-1.6%) | -$11.20 M(+1.1%) |
| June 2000 | - | -$2.09 M(+3.0%) | -$11.07 M(-5.2%) |
| Mar 2000 | - | -$2.03 M(-59.5%) | -$11.68 M(-6.7%) |
| Dec 1999 | -$12.46 M(+80.6%) | -$5.02 M(+159.6%) | -$12.52 M(+34.6%) |
| Sept 1999 | - | -$1.93 M(-28.4%) | -$9.30 M(+3.7%) |
| June 1999 | - | -$2.70 M(-5.9%) | -$8.97 M(+12.6%) |
| Mar 1999 | - | -$2.87 M(+59.4%) | -$7.97 M(+20.7%) |
| Dec 1998 | -$6.90 M(+11.3%) | -$1.80 M(+12.4%) | -$6.60 M(+4.7%) |
| Sept 1998 | - | -$1.60 M(-5.9%) | -$6.30 M(+1.6%) |
| June 1998 | - | -$1.70 M(+13.3%) | -$6.20 M(+12.7%) |
| Mar 1998 | - | -$1.50 M(0.0%) | -$5.50 M(-14.1%) |
| Dec 1997 | -$6.20 M(+31.9%) | -$1.50 M(0.0%) | -$6.40 M(+1.6%) |
| Sept 1997 | - | -$1.50 M(+50.0%) | -$6.30 M(+1.6%) |
| June 1997 | - | -$1.00 M(-58.3%) | -$6.20 M(0.0%) |
| Mar 1997 | - | -$2.40 M(+71.4%) | -$6.20 M(+37.8%) |
| Dec 1996 | -$4.70 M(+571.4%) | -$1.40 M(0.0%) | -$4.50 M(-27.4%) |
| Sept 1996 | - | -$1.40 M(+40.0%) | -$6.20 M(+51.2%) |
| June 1996 | - | -$1.00 M(+42.9%) | -$4.10 M(+70.8%) |
| Mar 1996 | - | -$700.00 K(-77.4%) | -$2.40 M(+140.0%) |
| Dec 1995 | -$700.00 K | -$3.10 M(-542.9%) | -$1.00 M(-147.6%) |
| Sept 1995 | - | $700.00 K(0.0%) | $2.10 M(+50.0%) |
| June 1995 | - | $700.00 K(0.0%) | $1.40 M(+100.0%) |
| Mar 1995 | - | $700.00 K | $700.00 K |
FAQ
- What is AIM ImmunoTech annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for AIM ImmunoTech?
- What is AIM ImmunoTech annual EBITDA year-on-year change?
- What is AIM ImmunoTech quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly EBITDA year-on-year change?
- What is AIM ImmunoTech TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for AIM ImmunoTech?
- What is AIM ImmunoTech TTM EBITDA year-on-year change?
What is AIM ImmunoTech annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of AIM is -$31.68 M
What is the all time high annual EBITDA for AIM ImmunoTech?
AIM ImmunoTech all-time high annual earnings before interest, taxes, depreciation & amortization is $2.07 M
What is AIM ImmunoTech annual EBITDA year-on-year change?
Over the past year, AIM annual earnings before interest, taxes, depreciation & amortization has changed by -$12.01 M (-61.07%)
What is AIM ImmunoTech quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AIM is -$3.44 M
What is the all time high quarterly EBITDA for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.04 M
What is AIM ImmunoTech quarterly EBITDA year-on-year change?
Over the past year, AIM quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.33 M (+55.75%)
What is AIM ImmunoTech TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AIM is -$26.19 M
What is the all time high TTM EBITDA for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.64 M
What is AIM ImmunoTech TTM EBITDA year-on-year change?
Over the past year, AIM TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.60 M (-21.29%)